1. Home
  2. BLTE vs LW Comparison

BLTE vs LW Comparison

Compare BLTE & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$158.49

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo Lamb Weston Holdings Inc.

LW

Lamb Weston Holdings Inc.

HOLD

Current Price

$43.69

Market Cap

5.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
LW
Founded
2018
1950
Country
United States
United States
Employees
N/A
10100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.7B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
BLTE
LW
Price
$158.49
$43.69
Analyst Decision
Strong Buy
Hold
Analyst Count
7
7
Target Price
$198.00
$44.14
AVG Volume (30 Days)
117.4K
2.1M
Earning Date
05-08-2026
04-01-2026
Dividend Yield
N/A
3.53%
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
N/A
N/A
Revenue This Year
N/A
$4.26
Revenue Next Year
$492.11
N/A
P/E Ratio
N/A
$33.28
Revenue Growth
N/A
N/A
52 Week Low
$56.68
$37.62
52 Week High
$200.00
$67.07

Technical Indicators

Market Signals
Indicator
BLTE
LW
Relative Strength Index (RSI) 43.63 52.52
Support Level $157.63 $39.70
Resistance Level $161.28 $46.61
Average True Range (ATR) 6.26 1.42
MACD -1.15 0.04
Stochastic Oscillator 17.27 45.70

Price Performance

Historical Comparison
BLTE
LW

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

Share on Social Networks: